levosimendan

FDA Says Tenax Therapeutics Can Submit Levosimendan Ph II Protocol for Pulmonary Hypertension Under Existing IND
CP Wire
Thu, 04/5/18 - 08:49 am
Tenax Therapeutics
levosimendan
clinical trials
FDA
FDA Says Tenax Therapeutics Can Submit Levosimendan Ph II Protocol for Pulmonary Hypertension Under Existing IND
Thu, 04/5/18 - 08:46 am
Tenax Therapeutics
levosimendan
pulmonary hypertension